World Journal of Experimental Medicine - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4609)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

227

WORD

142

HTML

2064

Figures (1-2)

192

Tables (1-2)

183

Sum=2808

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

191

Download

754

Sum=945

Publishing Process of This Article

Item

Count

Browse

284

Download

572

Sum=856

May 20, 2022 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Bajpai J, Pradhan A, Verma AK, Kant S. Use of hydroxychloroquine and azithromycin combination to treat the COVID-19 infection. World J Exp Med 2022; 12(3): 44-52 [PMID: 35765514 DOI: 10.5493/wjem.v12.i3.44]
URL:	https://www.wjgnet.com/2220-315x/full/v12/i3/44.htm

Number	Citing Articles
1	Raktim Swarnakar, Sankha Subhra Roy, Shiv Lal Yadav. Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis. World Journal of Experimental Medicine 2022; 12(6): 108-110 doi: 10.5493/wjem.v12.i6.108 Abstract(349) \| Core Tip(344) \| Full Article(HTML)(1108) \| Full Article (PDF)-505K(112) \| Full Article (Word)-104K(35) \| Audio-668K(8) \| Peer-Review Report-379K(35) \| Answering Reviewers-123K(36) \| Times Cited (1) \| Total Visits (3959) \| Open
2	Paloma Seidel, Eva Spukti, Kerstin Steinbrink, Dieter Metze, Markus Böhm. Hydroxychloroquin – nicht immer ein harmloses Medikament für den Off-label-Gebrauch in der Dermatologie. Die Dermatologie 2024; doi: 10.1007/s00105-024-05294-y
3	Wassan Nori, Nabeeha Najatee Akram, Raid M Al-Ani. Update on hydroxychloroquine use in pregnancy. World Journal of Experimental Medicine 2023; 13(4): 99-101 doi: 10.5493/wjem.v13.i4.99 Abstract(317) \| Core Tip(289) \| Full Article(HTML)(1215) \| Full Article with Cover (PDF)-545K(52) \| Full Article (Word)-103K(32) \| Audio-1788K(1) \| Peer-Review Report-230K(28) \| Answering Reviewers-85K(32) \| Full Article (PDF)-351K(95) \| Full Article (XML)-43K(34) \| Times Cited (0) \| Total Visits (3034) \| Open
4	Neelam Kumari, Sarika Shukla, Deevena Jemima, Anjali Singh, Surya Kant. COVID-19 lockdown – Health and nutritional status of the general public in Lucknow. IP Indian Journal of Immunology and Respiratory Medicine 2022; 7(3): 104 doi: 10.18231/j.ijirm.2022.025
5	Elizabeth A.M. Frost. Long COVID—Will It Never End?. Topics in Pain Management 2022; 38(4): 1 doi: 10.1097/01.TPM.0000902752.53691.86
6	Marco Zeppieri. Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis. World Journal of Experimental Medicine 2023; 13(4): 95-98 doi: 10.5493/wjem.v13.i4.95 Abstract(308) \| Core Tip(309) \| Full Article(HTML)(922) \| Full Article with Cover (PDF)-553K(45) \| Full Article (Word)-103K(35) \| Audio-345K(3) \| Peer-Review Report-218K(27) \| Answering Reviewers-111K(30) \| Full Article (PDF)-359K(61) \| Full Article (XML)-43K(27) \| Times Cited (0) \| Total Visits (2754) \| Open